Microvascular dysfunction and heart failure with preserved ejection fraction
Clinical Research in Cardiology · 2026
DOI: 10.1007/s00392-025-02822-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Research in Cardiology, 2026. Verfasst von Ornela Velollari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: Stroke Volume, Heart Failure, Ventricular Function, Left, Microcirculation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin der Johannes Gutenberg-Universität Mainz.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background and aim The impact of coronary microvascular dysfunction (CMD) on parameters of systolic and diastolic function, particularly in patients with heart failure and preserved ejection fraction (HFpEF), is poorly understood. Although these conditions often overlap, their combined impact on parameters of systolic and diastolic function remains unexplored.
Methods
Consecutive patients undergoing invasive CMD assessment were enrolled. Systolic function was assessed by global longitudinal strain (GLS), diastolic function by E/E’, left atrial reservoir strain (LARS), and non-invasive single-beat pressure–volume relationship stiffness constant (β) estimation.
Results
Of 145 patients, 72 (49.7%) had CMD, 35 (24%) HFpEF, and 23 (16%) both conditions. HFpEF was twice as prevalent in CMD patients as compared to patients without CMD (32% vs. 16%, p = 0.034). Both CMD was associated with parameters of both diastolic (E/E’ β = 0.29, p < 0.001, LV stiffness constant β = 0.23; p = 0.006, and LARS β = -0.21, p = 0.02) and systolic function (GLS β = 0.31, p < 0.001). The presence of CMD was associated with an impairment in LV stiffness both in patients with and without HFpEF (p for interaction = 0.044).
Conclusion
HFpEF is highly prevalent in patients with CMD, and CMD is associated with both systolic and diastolic dysfunction. In patients with HFpEF, an additional worsening of diastolic function is observed. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.
- German Centre for Cardiovascular Research (DZHK), Standort RheinMain, Mainz, Germany.
- Department of Interventional Cardiology, Misericordia Hospital, Azienda USL (Unità Sanitaria Locale) Toscana Sud Est, Grosseto, Italy.
- Department of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany. kresojak@uni-mainz.de.
- German Centre for Cardiovascular Research (DZHK), Standort RheinMain, Mainz, Germany. kresojak@uni-mainz.de.
Förderung
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Zitieren
APA
Velollari, O., Biancofiore, A., Olschewski, M., Ullrich-Daub, H., Münzel, T., Rommel, K. P., Lurz, P., Gori, T., & Kresoja, K. P. (2026). Microvascular dysfunction and heart failure with preserved ejection fraction. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-025-02822-1
Vancouver
Velollari O, Biancofiore A, Olschewski M, Ullrich-Daub H, Münzel T, Rommel KP, et al. Microvascular dysfunction and heart failure with preserved ejection fraction. Clinical Research in Cardiology. 2026. doi:10.1007/s00392-025-02822-1
BibTeX
@article{Velollari2026,
author = {Velollari, Ornela and Biancofiore, Antonio and Olschewski, Maximilian and Ullrich-Daub, Helen and Münzel, Thomas and Rommel, Karl-Philipp and Lurz, Philipp and Gori, Tommaso and Kresoja, Karl-Patrik},
title = {Microvascular dysfunction and heart failure with preserved ejection fraction},
journal = {Clinical Research in Cardiology},
year = {2026},
doi = {10.1007/s00392-025-02822-1}
}
EUVIMED